Availability of and Access to Orphan Drugs: An International Comparison of Pharmaceutical Treatments for Pulmonary Arterial Hypertension, Fabry Disease, Hereditary Angioedema and Chronic Myeloid Leukaemia
Year of publication: |
2011
|
---|---|
Authors: | Blankart, Carl Rudolf. ; Stargardt, Tom ; Schreyogg, Jonas Schreygg |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 29.2011, 1, p. 63-82
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Chronic-myeloid-leukaemia | treatment | Cost-effectiveness | Decision-making | Fabry's-disease | Formularies | Hereditary-angioedema | Orphan-drugs | Pricing | Pulmonary-hypertension | Regulatory-process | Reimbursement |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Ragupathy, Rajan, (2012)
-
Common Drug Review Recommendations: An Evidence Base for Expectations?
Rocchi, Angela, (2012)
-
Subgroups and Heterogeneity in Cost-Effectiveness Analysis
Sculpher, Mark, (2008)
- More ...
-
Baumler, Michael Bumler, (2012)
-
Cost of Illness of Cystic Fibrosis in Germany: Results from a Large Cystic Fibrosis Centre
Heimeshoff, Mareike, (2012)
-
Bürgerversicherung: Die Wirkung von Kopfprämien auf den Arbeitsmarkt
Farhauer, Oliver, (2004)
- More ...